Literature DB >> 17229746

Reversible encephalopathy associated with cholesterol embolism syndrome: magnetic resonance imaging and pathological findings.

F Andreux1, B Marro, N El Khoury, D Seilhean, S Alamowitch.   

Abstract

We describe a patient found to have acute diffuse and reversible encephalopathy on magnetic resonance imaging (MRI) associated with cholesterol emboli syndrome (CES). The initial MRI showed extensive white matter, basal ganglia and cortical damage without evidence of brain infarction. Dramatic clinical and MRI improvement was observed with corticosteroids. Pathologically, cholesterol crystal emboli were found in the lumen of skin and brain arteries and were associated with varying degrees of inflammation of the arteriole wall. This case suggests that CES may be responsible for extensive, acute and reversible encephalopathy underlined by an inflammation of brain arteries.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17229746      PMCID: PMC2077650          DOI: 10.1136/jnnp.2006.099770

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  8 in total

Review 1.  The evaluation of corticosteroid therapy in conjunction with plasma exchange in the treatment of renal cholesterol embolic disease. A report of 5 cases.

Authors:  M Hasegawa; S Kawashima; M Shikano; H Hasegawa; M Tomita; K Murakami; H Kushimoto; H Katsumata; T Toba; A Oohashi; S Hiramitsu; K Matsunaga
Journal:  Am J Nephrol       Date:  2000 Jul-Aug       Impact factor: 3.754

2.  Supportive treatment improves survival in multivisceral cholesterol crystal embolism.

Authors:  X Belenfant; A Meyrier; C Jacquot
Journal:  Am J Kidney Dis       Date:  1999-05       Impact factor: 8.860

Review 3.  Cholesterol crystal embolization: a review of 221 cases in the English literature.

Authors:  M J Fine; W Kapoor; V Falanga
Journal:  Angiology       Date:  1987-10       Impact factor: 3.619

4.  Treatment of atheroembolization with corticosteroids.

Authors:  S J Mann; T A Sos
Journal:  Am J Hypertens       Date:  2001-08       Impact factor: 2.689

5.  Clinical characteristics of pathologically proved cholesterol emboli to the brain.

Authors:  M A Ezzeddine; J M Primavera; J Rosand; E T Hedley-Whyte; G Rordorf
Journal:  Neurology       Date:  2000-04-25       Impact factor: 9.910

6.  Cholesterol embolism as a cause of transient ischemic attacks and cerebral infarction.

Authors:  M F Beal; R S Williams; E P Richardson; C M Fisher
Journal:  Neurology       Date:  1981-07       Impact factor: 9.910

7.  Lacunar infarctions due to cholesterol emboli.

Authors:  P Laloux; J M Brucher
Journal:  Stroke       Date:  1991-11       Impact factor: 7.914

8.  A reversible posterior leukoencephalopathy syndrome.

Authors:  J Hinchey; C Chaves; B Appignani; J Breen; L Pao; A Wang; M S Pessin; C Lamy; J L Mas; L R Caplan
Journal:  N Engl J Med       Date:  1996-02-22       Impact factor: 91.245

  8 in total
  2 in total

1.  Steroid-responsive leucoencephalopathy due to cholesterol embolism.

Authors:  Patrice Laloux
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-02       Impact factor: 10.154

Review 2.  Breath-Hold Diving-Related Decompression Sickness with Brain Involvement: From Neuroimaging to Pathophysiology.

Authors:  José Manuel Sánchez-Villalobos; María Lorenza Fortuna-Alcaraz; Laura Serrano-Velasco; Ángel Pujante-Escudero; Carmen María Garnés-Sánchez; Jorge Edverto Pérez-Garcilazo; Agustín Olea-González; José Antonio Pérez-Vicente
Journal:  Tomography       Date:  2022-04-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.